Lund, Sweden

Christina Furebring

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Christina Furebring: Pioneering Innovations in Bispecific Polypeptides**

Introduction

Christina Furebring, an accomplished inventor based in Lund, Sweden, has made significant contributions to the field of biomedicine. With a remarkable portfolio of 18 patents, she stands out for her innovative work in the development of bispecific polypeptides.

Latest Patents

Among Christina's notable patents is the invention of bispecific polypeptides against CD137. This invention provides novel bispecific polypeptides that feature a first binding domain, designated B1, capable of specifically binding to CD137, alongside a second binding domain, designated B2, which targets a tumour cell-associated antigen. The patent also encompasses pharmaceutical compositions of these polypeptides and their medical applications. Another significant patent involves bispecific polypeptides, including bispecific antibodies, that comprise a first binding domain specifically binding to one T cell target and a second binding domain for a different T cell target. This invention further details the compositions of these bispecific polypeptides and outlines methods and therapeutic uses.

Career Highlights

Throughout her career, Christina has collaborated with leading organizations such as Alligator Bioscience AB and Aptevo Research and Development LLC. Her work at these companies has significantly advanced the development of innovative therapeutics aimed at improving cancer treatments.

Collaborations

Christina has collaborated with notable peers in her field, including Peter Ellmark and Sara Fritzell. These collaborations have not only enriched her research but have also contributed to the broader scientific community's understanding of bispecific polypeptides.

Conclusion

Christina Furebring exemplifies the spirit of innovation in the field of biomedicine. Through her pioneering patents and collaborative efforts, she continues to influence advancements in medical science, showcasing the important role of inventors in the ongoing quest for effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…